Plan B Advocates Don't Grasp FDA Process, 2nd Circ. Told

Law360, New York (May 28, 2013, 2:58 PM EDT) -- The U.S. Food and Drug Administration on Friday hit back at reproductive health advocates who asked the Second Circuit not to stay an order making emergency contraceptive Plan B available over the counter without age restrictions, saying the advocates didn’t properly understand the FDA approval process.

According to the FDA, the coalition of health groups and private citizens which urged the circuit court not to stay U.S. District Judge Edward R. Korman's order making Plan B, Plan B One-Step and generic equivalents available over the counter to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.